CTIS2023-505729-15-00
Active, not recruiting
Phase 1
Evaluation of the safety of inhaled sedation with Isoflurane in head trauma patients.
Centre Hospitalier Universitaire Grenoble Alpes0 sites30 target enrollmentJune 2, 2023
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Head trauma patient
- Sponsor
- Centre Hospitalier Universitaire Grenoble Alpes
- Enrollment
- 30
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Comparison of an inhaled sedation strategy with an intravenous sedation strategy in intensive care patients treated with invasive mechanical ventilation: INASED studyCTIS2024-513530-37-00Centre Hospitalier Regional Et Universitaire De Brest250
Recruiting
Not Applicable
Inhaled Amikacin for Ventilator Associated Pneumonia (VAP)PACTR201909502649249Faculty of Medicine Alexandria University45
Active, not recruiting
Phase 1
Comparison of an inhaled sedation strategy to an intravenous sedation strategy in ICU patients treated with invasive mechanical ventilatioPrevention of deliriumMedDRA version: 21.0Level: LLTClassification code 10072852Term: Post-injection delirium/sedation syndromeSystem Organ Class: 100000004852Therapeutic area: Body processes [G] - Physiological processes [G07]EUCTR2019-004537-16-FRCHRU de Brest250
Not yet recruiting
Not Applicable
Inhibitory effect of gas anesthetics on neurophysiological monitoring in young childreSpinal cord diseasesSpinalD013118JPRN-jRCT1041220109Kojima Fumio Taiki20
Recruiting
Phase 3
Evaluation of the efficacy and safety of inhaled magnesium sulfate in combination with standard treatment in Covid-19 patientsCovid-19.COVID-19, virus identifiedU07.1IRCT20191211045691N1ational Research Institute of Tuberculosis and Lung Diseases(NRITLD), Masih Daneshvari Hospital100